These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32766126)

  • 1. High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
    Wang Y; Zhang S; Wang H; Cui Y; Wang Z; Cheng X; Li W; Hou J; Ji Y; Liu T
    Front Oncol; 2020; 10():966. PubMed ID: 32766126
    [No Abstract]   [Full Text] [Related]  

  • 2. LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer.
    Zang D; Zhang C; Li C; Fan Y; Li Z; Hou K; Che X; Liu Y; Qu X
    Am J Cancer Res; 2020; 10(3):1026-1044. PubMed ID: 32266108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
    Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
    Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LUM Expression and Its Prognostic Significance in Gastric Cancer.
    Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
    Front Oncol; 2020; 10():605. PubMed ID: 32500021
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer.
    Lu S; Peng L; Ma F; Chai J; Hua Y; Yang W; Zhang Z
    J Gastrointest Surg; 2023 Feb; 27(2):233-249. PubMed ID: 36451060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of SETBP1 in Gastric Cancer: Friend or Foe.
    Fang F; Liu C; Li Q; Xu R; Zhang T; Shen X
    Front Oncol; 2022; 12():908943. PubMed ID: 35898891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic potential of ribosome 18S RNA m
    Wang Z; Liu J; Yang Y; Xing C; Jing J; Yuan Y
    Cancer Cell Int; 2021 Oct; 21(1):569. PubMed ID: 34702266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer.
    Bao B; Zheng C; Yang B; Jin Y; Hou K; Li Z; Zheng X; Yu S; Zhang X; Fan Y; Qu X; Liu Y; Che X
    Front Oncol; 2019; 9():1243. PubMed ID: 31803620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
    Zhao Z; Li S; Li S; Wang J; Lin H; Fu W
    Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.
    Gong X; Hou D; Zhou S; Tan J; Zhong G; Yang B; Xie L; Han F; Zhong L
    Front Oncol; 2023; 13():1144775. PubMed ID: 37274237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 12. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
    Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 15. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
    Huang C; Zhao J; Luo C; Zhu Z
    Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
    [No Abstract]   [Full Text] [Related]  

  • 16. Construction and evaluation of a prognostic risk assessment model of gastric cancer by using hypoxia features.
    Zhu X; Wang J; Jin X; Chen Y; Hu L; Zhao J
    Mutat Res; 2022; 825():111795. PubMed ID: 36049301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression Analysis.
    Zhang S; Zang D; Cheng Y; Li Z; Yang B; Guo T; Liu Y; Qu X; Che X
    J Cancer; 2020; 11(10):3041-3051. PubMed ID: 32226519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
    Zhang X; Zhan D; Li Y; Wang H; Cheng C; Yao Y; Jia J
    Med Sci Monit; 2020 May; 26():e921775. PubMed ID: 32392186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():765569. PubMed ID: 35154268
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.